Medpace in the News
2009
Dr. Xiaoxiong (Jim) Wei, Executive Director, Clinical Pharmacology, recently facilitated China's SFDA/CDE workshop, "Science-Based Regulatory Decision-Making," along with other industry leaders as a member of the FDA Alumni Association (FDAAA)
FDA Alumni Association, June 2009
Medpace, Inc. takes the top spot as the best CRO for Overall Working Relationship as rated by U.S. Investigative Sites
The CenterWatch Monthly, June 2009
Press Releases
2010
Medpace Reference Laboratories (MRL) central labs in China and India achieve CAP Accreditation, NGSP Level 1 and CDC Lipid Standardization Part III standardization, completing the company’s ability to deliver global, identical, highly standardized laboratory services in its own facilities
Medpace, Inc. acquires Symbios Clinical, a US-based Clinical Research Organization (CRO) Specializing in Medical Device Trials
Medpace Executive Director David G. Orloff, MD, to co-chair Educational Satellite Symposia, New Frontiers in Anti-Atherosclerotic Therapies
Medpace announces the addition of Samer E. Kaba, MD, Medical Director, strengthening therapeutic expertise in neuroscience drug development services
Medpace Medical Director, Jim Wei, MD, PhD to present at the Outsourcing Clinical Trials Conference, January 27-28, 2010
Medpace, Inc. continues their European expansion with the acquisition of Medical Consulting Dr. Schlichtiger GmbH
Medpace Sets Groundbreaking for Global Headquarters in Madisonville
2009
Medpace therapeutic expert, Charles Schmidt, MD, PhD to present at the Paediatric Drug Development and Clinical Trials in Brussels, November 17-18, 2009
Medpace Inc. expands therapeutic capabilities with the acquisition of Pharma Brains AG, a European CRO with global experience in oncology drug development
Medpace therapeutic expert, David G. Orloff, MD, to present at the next Drug Information Association (DIA) conference, September 23-24, 2009
Medpace announces the addition of Patricia E. Cole, PhD, MD, Executive Director Imagepace, strengthening Medpace services in clinical imaging
Medpace, Inc. takes the top spot as the best CRO for Overall Working Relationship as rated by U.S. Investigative Sites in CenterWatch, 2009 Site Survey
New Clinical Trial Customers Punctuate Success of Phase Forward-Medpace Relationship
Medpace, Inc. celebrates the first year success at the Medpace Clinical Pharmacology Unit (MCPU)
Medpace adds Executive Medical Director, Dr. Thomas G. Todaro, MD, JD, FACC, FCLM, strengthening therapeutic expertise in cardiology
Medpace recognized with two awards for achieving outstanding revenue growth in the Cincinnati business community
2008
Medpace Strengthens Clinical Development Services with Medpace Bioanalytical Laboratories
Medpace adds Medical Director, Dr. Bernard E. Ilson, MD, FACP building their Clinical Expertise in Nephrology and Clinical Pharmacology
Medpace Selects Madisonville Site for Global Headquarters
Medpace Hires Industry Expert to Direct New Bioanalytical Laboratories
Medpace Director of Clinical Pharmacology, Jim Wei, MD, PhD, Embarks on a Regulatory Policy Speaking Tour in China in May
Medpace Hires Clinical Pharmacologist, Jim Wei, MD, PhD
2007
Medpace Opens Clinical Pharmacology Unit in Cincinnati, Ohio
Medpace Strengthens Presence in Central Europe